Katherine Berry

3.9k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Katherine Berry is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Katherine Berry has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Surgery. Recurrent topics in Katherine Berry's work include Muscle Physiology and Disorders (11 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA modifications and cancer (7 papers). Katherine Berry is often cited by papers focused on Muscle Physiology and Disorders (11 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA modifications and cancer (7 papers). Katherine Berry collaborates with scholars based in United States, Italy and Egypt. Katherine Berry's co-authors include Linda Lowes, Lindsay N. Alfano, Jerry R. Mendell, Nathalie Goemans, James Shao, Edward M. Kaye, Eugenio Mercuri, Kevin M. Flanigan, Brian K. Kaspar and Louise R. Rodino‐Klapac and has published in prestigious journals such as Neurology, Annals of Neurology and Phytochemistry.

In The Last Decade

Katherine Berry

41 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longitudinal effect of eteplirsen versus historical control on ambulation in D uchenne muscular dystrophy

2015 372 citations Jerry R. Mendell, Nathalie Goemans et al. profile →

Peers

Countries citing papers authored by Katherine Berry

Since Specialization

Citations

This map shows the geographic impact of Katherine Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Berry more than expected).

Fields of papers citing papers by Katherine Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Berry. The network helps show where Katherine Berry may publish in the future.

Co-authorship network of co-authors of Katherine Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Berry. A scholar is included among the top collaborators of Katherine Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Berry. Katherine Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Infrasellar Nasopharyngeal Craniopharyngiomas: An Individual Participant Data Meta-Analysis and Review of the Literature 2024 ·World Neurosurgery ·(unknown), Evan Luther, Ian Ramsay, Katherine Berry, Lekhaj Daggubati, Alexis A. Morell, (unknown), Daniel G. Eichberg, Ashish H. Shah, Ricardo J. Komotar, Michael E. Ivan	1
2	Effects of Obesity on Cervical Disc Arthroplasty Complications 2023 ·Neurospine ·Katherine Berry, Vaidya Govindarajan, (unknown), (unknown), (unknown), Evan Luther, Allan D. Levi	3
3	Surgically Treated Brain Metastases from Uterine Origin: A Case Series and Systematic Review 2023 ·World Neurosurgery ·(unknown), (unknown), (unknown), (unknown), Katherine Berry, Alexis A. Morell, (unknown), Lekhaj Daggubati, Dominique Higgins, Matthew Schlumbrecht, Ricardo J. Komotar, Ashish H. Shah, Michael E. Ivan	2
4	Multilevel Endoscopic Transforaminal Interbody Fusion for Severe Discitis, Osteomyelitis, and Kyphotic Deformity in the Lumbar Spine: 2-Dimensional Operative Video 2023 ·Operative Neurosurgery ·Aria Jamshidi, Katherine Berry, Michael Y. Wang	0
5	Same-day discharge after brain tumor resection: a prospective pilot study 2022 ·Journal of Neuro-Oncology ·(unknown), Daniel G. Eichberg, Alexis A. Morell, Ashish H. Shah, Long Di, Katherine Berry, Evan Luther, Victor M. Lu, Nitesh V. Patel, Michael E. Ivan, Ricardo J. Komotar	13
6	Surgical Approaches to Thalamic Gliomas: A Systematic Review 2022 ·World Neurosurgery ·(unknown), (unknown), (unknown), (unknown), Alexis A. Morell, Lekhaj Daggubati, Katherine Berry, Daniel G. Eichberg, Jay Chandar, Ashish H. Shah, Evan Luther, Victor M. Lu, Ricardo J. Komotar, Michael E. Ivan	3
7	Navigating radial artery loops in neurointerventions 2020 ·Journal of NeuroInterventional Surgery ·Evan Luther, Joshua D. Burks, (unknown), (unknown), (unknown), Katherine Berry, David J. McCarthy, Vasu Saini, Michael Silva, (unknown), (unknown), Dileep R. Yavagal, Eric C. Peterson, Michael R. Levitt, Robert M. Starke	16
8	Hospital teaching status associated with reduced inpatient mortality and perioperative complications in surgical neuro-oncology 2020 ·Journal of Neuro-Oncology ·Evan Luther, David J. McCarthy, Katherine Berry, (unknown), Ashish H. Shah, Daniel G. Eichberg, Ricardo J. Komotar, Michael E. Ivan	14
9	Neuro-oncology practice guidelines from a high-volume surgeon at the COVID-19 epicenter 2020 ·Journal of Clinical Neuroscience ·Evan Luther, Joshua D. Burks, Daniel G. Eichberg, Gregory W. Basil, Katherine Berry, Victor M. Lu, Ashish H. Shah, Gurvinder Kaur, Michael E. Ivan, Ricardo J. Komotar	6
10	The Effects of Lockdown During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Neurotrauma-Related Hospital Admissions 2020 ·World Neurosurgery ·Javier Figueroa, (unknown), Michael Kader, Katherine Berry, (unknown), (unknown), Steven Vanni, Jonathan Jagid	29
11	Laser Ablation for Cerebral Metastases 2020 ·Neurosurgery Clinics of North America ·Evan Luther, (unknown), (unknown), David J. McCarthy, Daniel G. Eichberg, Ashish H. Shah, (unknown), Katherine Berry, Michael Kader, Michael E. Ivan, Ricardo J. Komotar	12
12	SMA THERAPIES I 2018 ·Neuromuscular Disorders ·Richard Shell, (unknown), W. David Arnold, (unknown), T. Prior, (unknown), Grace Paul, Linda Lowes, Lindsay N. Alfano, Katherine Berry, (unknown), J. T. Kissel, (unknown), Francis G. Ogrinc, (unknown), Courtney Wells, Kathrin Meyer, Shibi Likhite, (unknown), (unknown)	2
13	AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Patients Treated Early with the Proposed Therapeutic Dose Were Able to Sit Unassisted at a Younger Age (S29.002) 2018 ·Neurology ·Lindsay N. Alfano, Linda Lowes, Samiah Al-Zaidy, Richard Shell, W. David Arnold, Louise R. Rodino‐Klapac, Thomas W. Prior, Katherine Berry, Kathleen Church, John T. Kissel, Sukumar Nagendran, James L’Italien, Douglas M. Sproule, Courtney Wells, Arthur H.M. Burghes, Kevin D. Foust, Kathrin Meyer, Shibi Likhite, Brian K. Kaspar, Jerry R. Mendell	1
14	The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials 2017 ·Neuromuscular Disorders ·Lindsay N. Alfano, N. Miller, Katherine Berry, Han Yin, (unknown), Kevin M. Flanigan, Jerry R. Mendell, Linda Lowes	20
15	Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes 2017 ·Molecular Therapy ·Jerry R. Mendell, Zarife Sahenk, Samiah Al-Zaidy, Louise R. Rodino‐Klapac, Linda Lowes, Lindsay N. Alfano, Katherine Berry, N. Miller, Mehmet E. Yalvaç, Igor Dvorchik, Melissa Moore‐Clingenpeel, Kevin M. Flanigan, Kathleen Church, Kim Shontz, (unknown), Sarah Lewis, Markus McColly, Mark Hogan, Brian K. Kaspar	80
16	Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) and Loss of Ambulation (LOA) (S42.004) 2017 ·Neurology ·(unknown), Nathalie Goemans, (unknown), (unknown), (unknown), Katherine Berry, (unknown), (unknown), Eugenio Mercuri, (unknown)	2
17	Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Clinical Update and Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) (S28.001) 2016 ·Neurology ·Jerry R. Mendell, Nathalie Goemans, Louise R. Rodino‐Klapac, Zarife Sahenk, Linda Lowes, Lindsay N. Alfano, Katherine Berry, (unknown), Sarah Lewis, Kim Shontz, James Shao, Petra W. Duda, (unknown), Frédéric Schnell, (unknown), Bruce M. Wentworth, Edward M. Kaye, Eugenio Mercuri, (unknown)	1
18	A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design 2016 ·Molecular Genetics and Metabolism ·(unknown), Haiyan Fu, Douglas M. McCarty, Kelly McNally, (unknown), Nicholas Zumberge, Lisa Martin, Shawn C. Aylward, Lindsay N. Alfano, Katherine Berry, Linda Lowes, Marco Corridore, (unknown), Kim L. McBride, Kevin M. Flanigan	40
19	A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy 2014 ·Molecular Therapy ·Jerry R. Mendell, Zarife Sahenk, Vinod Malik, Ana M. Gómez, Kevin M. Flanigan, Linda Lowes, Lindsay N. Alfano, Katherine Berry, Eric S. Meadows, Sarah Lewis, Lyndsey Braun, Kim Shontz, (unknown), K. Reed Clark, Xiomara Q. Rosales, Samiah Al-Zaidy, Alessandra Govoni, Louise R. Rodino‐Klapac, Mark Hogan, Brian K. Kaspar	189
20	Surgical Closure of the Larynx for Intractable Aspiration 1980 ·Archives of Otolaryngology - Head and Neck Surgery ·Clarence T. Sasaki, Gregory Milmoe, Eiji Yanagisawa, Katherine Berry, John A. Kirchner	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact